Nausea News and Research

RSS

Nausea is the sensation of unease and discomfort in the upper stomach and head with an urge to vomit. An attack of nausea is known as a qualm.

Targeted nalmefene with simple medical management in the treatment of heavy drinkers

Problem drinkers who took a craving-curbing drug whenever they felt the desire to imbibe reported fewer heavy drinking days each month than drinkers who took a look-alike placebo pill, but both groups reported marked reductions in heavy drinking days.

4 Jul 2007

Canadians warned about tainted and fake toothpaste

Canadians are being warned about a counterfeit toothpaste on sale in stores which contains harmful ingredients.

2 Jul 2007

Meningococcal vaccine now recommended for ages 11 to 18

Recommendations by the Centers for Disease Control and Prevention, (CDC), that all young people aged 11 to 18 should get a shot that protects them from the most dangerous type of meningitis, has been applauded by the National Foundation for Infectious Diseases (NFID).

28 Jun 2007

Bayer and Onyx submit supplemental NDA for Nexavar

Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals have announced that a Supplemental New Drug Application (sNDA) for Nexavar (sorafenib) tablets has been submitted to the U.S. Food and Drug Administration (FDA) for the treatment of patients with hepatocellular carcinoma (HCC), the most common form of liver cancer. Nexavar is currently approved in more than 50 countries for the treatment of advanced kidney cancer.

28 Jun 2007

Actavis launches Ondansetron tablets in the U.S.

Actavis Group has announced that it has launched Ondansetron Tablets in the U.S. Actavis will market the product under an agreement with Natco Pharma Limited. Distribution of the product will commence immediately.

28 Jun 2007

Echinacea helps protect against colds

According to new research Echinacea, a herbal remedy traditionally used to help fight infections does work and can in fact reduce the chances of catching a cold by more than half.

25 Jun 2007

Morning sickness may indicate lower risk of breast cancer

It may not seem so at the time, but women who suffer through morning sickness during their pregnancies actually may be fortunate.

23 Jun 2007

Latest food scare... sesame seeds with Salmonella

In the latest food scare to hit North America the Canadian Food Inspection Agency (CFIA) is warning the public not to consume certain sesame seeds because they may be contaminated with Salmonella.

21 Jun 2007

New treatments for migraines and chronic headaches

Twelve percent of the population, three quarters of them women, suffer at least occasionally from migraines and about 5 percent from chronic headaches.

20 Jun 2007

Genzyme announces results of clinical trials of Renvela and Renagel

Genzyme Corp. has announced the results of two new studies comparing a powder form of Renvela (sevelamer carbonate) to Renagel tablets (sevelamer hydrochloride), including one trial in which patients received the powder form three times per day, and one in which it was administered once per day.

19 Jun 2007

Carotenoids have even deeper health benefits than originally thought

Mom may have been right all along, especially when we were hormone-raging teenagers, eat your veggies and good things will happen.

14 Jun 2007

Asthma and allergic shock

Asthma, even a mild form, is the single most important factor that increases the risk of death from anaphylaxis (allergic shock), says a new report from Harvard Medical School, What To Do About Allergies .

14 Jun 2007

Examination of cancer-related fatigue

In a special publication sent to thousands of oncologists nationwide this month, University of Rochester Medical Center scientists offer an in-depth examination of cancer-related fatigue, with hope that a better understanding of the topic will prompt new research and treatment.

8 Jun 2007

Pramlintide treatment curbs fast food consumption and tendency to binge eat

The synthetic form of a hormone previously found to produce a feeling of fullness when eating and reduce body weight, also may help curb binge eating and the desire to eat high-fat foods and sweets.

8 Jun 2007

VEGF Trap (aflibercept) shows activity in patients with advanced ovarian cancer

Preliminary results of a randomized, international Phase II trial of VEGF Trap (aflibercept) show activity in patients with recurrent epithelial ovarian cancer (EOC) who had received three or four prior chemotherapy regimens and had become resistant to platinum-based chemotherapy agents.

5 Jun 2007